Stay updated on Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, representing a small update to the study page.
    Difference
    0.1%
    Check dated 2026-08-29T23:35:44.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5 in place of the previous v3.6.4, indicating a minor update to the study record metadata. This change does not modify the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-08T17:43:32.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, indicating a backend update. No study information or layout changes are introduced.
    Difference
    0.1%
    Check dated 2026-07-25T08:29:56.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.2 to v3.6.3, indicating a newer revision of the page. This is a minor update applied to the page's underlying revision tag.
    Difference
    0.1%
    Check dated 2026-07-03T22:13:54.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.0 to v3.6.2 to indicate a newer page revision. This change is metadata and does not modify the study content or its presentation.
    Difference
    0.1%
    Check dated 2026-06-26T23:55:40.000Z thumbnail image
  9. Check
    87 days ago
    Change Detected
    Summary
    The study page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and displays recruitment status as 'No longer looking for participants'. The Intervention/Treatment heading is updated and the revision footer shows Revision: v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:28:36.000Z thumbnail image

Stay in the know with updates to Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.